InvestorsHub Logo
Followers 97
Posts 3675
Boards Moderated 0
Alias Born 11/13/2018

Re: Number sleven post# 362524

Wednesday, 12/08/2021 8:24:34 PM

Wednesday, December 08, 2021 8:24:34 PM

Post# of 427370
On Law360, the headline is "Full Fed. Circ. Told Teva Overreacting In Skinny Label IP Case". The article is reporting on GSK's Brief filed on Monday, opposing En Banc review. According to the article, GSK's Brief says that Teva's concern that the decision will have a "seismic" impact on the drug industry, is "overblown".
Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent AMRN News